One Scan.
Transforming Complex Data into Clear Insights.

The SOZO® Digital Health Platform transforms complex fluid status and tissue composition into clear, decision-ready insights with a single scan for real-time care. With built-in thresholds, visual summaries, and trend tracking, it delivers personalized patient data clinicians can trust with immediate results.

Request Demo

Smiling male clinician in blue scrubs with stethoscope stands beside a digital medical scale on a platform.

Woman standing on a SOZO app

Delivering Next Generation, Personalized Patient Care

SOZO® Pro delivers clinical decision support at the point of care and is powered by bioimpedance spectroscopy (BIS), FDA-cleared for use in healthy and unhealthy populations, and for patients with pacemakers and implantable cardiac devices (ICDs):

  • Designed for clinical workflow: fast, intuitive, and repeatable.
  • Fits seamlessly into routine intake and follow up visits, with integrated weight capture.
    One scan delivers fluid and body composition trends in just 30 seconds.
  • Clear reporting with thresholds, historical data, and longitudinal tracking.
  • Reduces interpretation burden for clinicians and enables broader team use.

Learn More About BIS

Early & Accurate Detection

With precise and accurate fluid and body composition insights, clinicians can monitor and detect patient conditions before they become a problem, enabling informed treatment, recovery, and clinical decision-making with confidence.

Cancer Survivorship

Up to 58% of cancer patients are at risk for developing limb lymphedema.1 Treatment can cause changes in weight, muscle mass, bone health, and nutrition, impacting quality of life.

Wellness & Longevity

Closely monitor client response to wellness plans, including IV therapies, for sensitivities.

Add to cart button represented by a purple shopping basket icon

Medical Weight Management

Rapid weight reduction with GLP-1s or other therapies can affect muscle mass by up to 20%.2,3

Heart Health Management

Heart failure (HF) affects ~64 million people world-wide.4 ~50% of patients with heart failure are overweight or obese.5

Unlock Powerful Patient Data for Coordinated Care

With the MySOZO cloud-based platform, patient data is accessible at the point of care and across care teams, enabling personalized, coordinated care. Patient data may be integrated with the EHR for auto-documentation.

tablet with analytics data

PRIVACY & SECURITY

Patient Data is Secured across the Enterprise

Closed padlock icon on pale aqua background, representing security and privacy access

Private

Data stored in the HIPAA-compliant cloud is encrypted in-motion and at rest, and is HiTrust-Certified

Share icon button used to share this content

Connected

Compatible with leading EHR systems

Drawer Software & Hardware Specifications

SOZOapp: Android 8.1 or greater / iOS v13 or greater
MySOZO: Chrome or Edge Chromium or Firefox browser
SOZO Outputs: L-Dex® lymphedema index, HF-Dex® heart failure index, Total body water, Extracellular fluid, Intracellular fluid, Hy-Dex® hydration analysis Skeletal muscle mass, Fat mass, Fat-free Mass, Protein and minerals, Basal metabolic rate, Phase angle, Body mass index, Weight, Segmental outputs

Hardware Specifications

SOZO PRO

Tablet: Samsung Galaxy Tab A / iPad
Weight Capacity: Standing: 485.0 lb / 220.0 kg; Sitting: 750.0 lb / 340.0 kg
Weight: Device: 34.0 lb / 15.5 kg; Stand: 66.0 lb / 30.0 kg
Dimensions: 28.7 × 22.4 × 51.7 in / 72.9 × 57.0 × 131.4 cm (L × W × H)
Sensors: 8 stainless steel electrodes
Frequency Scan: 3 to 1000 kHz (256 frequencies)
Measurement Speed: Less than 30 seconds

SOZO

Tablet: Samsung Galaxy Tab A / iPad
Weight Capacity: Standing: 375lb / 170 kg, Sitting: 750 lb / 340 kg
Weight: SOZO Device: 10.0 lb / 4.5 kg, SOZOsupport Stand: 25.5 lb / 11.6 kg
Dimensions: 25.5 x 17.5 x 48.3 in / 64.8 x 44.5 x 122.6 cm (L x W x H)
Sensors: 8 stainless steel electrodes
Frequency Scan: 3 to 1000 kHz (256 frequencies)
Measurement Speed: Less than 30 seconds1
Experience the SOZO Digital Health Platform

References

  1. Ridner SH, et al. A Comparison of Bioimpedance Spectroscopy or Tape Measure Triggered Compression Intervention in Chronic Breast Cancer Lymphedema Prevention. Lymphatic Research and Biology 2022.
  2. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Survivorship V.1.2023. © National Comprehensive Cancer Network, Inc. 2023. All rights reserved. Accessed March 23, 2023. To view the most recent and complete version of the guideline, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.